<p>Several plant defense systems consist of enzymes that act on glucosides and produce a toxic compound. In the intact plant tissue the substrate and enzyme are kept apart. The system studied here consists of the substrate 2-O-β-D-glucopyranosyl-4-dihydroxy-1,4-benzoxazin-3-one and the enzyme glucan 1,3-β-glucosidase in rye. The aim was to determine the properties of a cell wall β-glucosidase. Two different systems for expression and purification of β-glucosidase fused to a tag were used: a 6xHistidine tag system and a thioredoxin tag system. The sequence of the β-glucosidase had previously been determined so now the gene was subcloned into E.coli. A direct PCR on colonies, a test expression, a restriction digestion of plasmids and sequencing was made to analyze the transformation, which all turned out successful. Then the β-glucosidase solubility was determined. Finally a purification of the β-glucosidase from E.coli under native conditions and a pNPG assay was carried out. For the (His)6-tagged protein, the recombinant β-glucosidase tended to end up in the insoluble pelleted fraction which indicated formation of inclusion bodies. The cell wall 1,3-β-glucosidase was soluble with the thioredoxin system, but the percentage of soluble protein fraction was around 5% only of the total protein. In eluates from a nickel-nitrilotriacetic acid column the presence of recombinant protein was confirmed with Western blot, but contaminating bands were also present. Purified elauted fractions did not exhibit detectable β-glucosidase activity. It was not possible to purify active enzyme. From a BLAST search it was clear that the most similar enzymes all had putative glycosylation sites and lack of glycosylation could be a reason for the protein not to fold properly.</p>

<p>Abstract</p><p>Crimean-Congo Hemorrhagic Fever virus (CCHF) and Lassa virus are giving sources illness to humans. In addition to zoonotic transmission, CCHF and Lassa virus can spread from person to person. After a short incubation period, CCHF and Lassa virus infections are characterized by a sudden onset of high fever, chills, headache and cough just like flu. Even some people are vomiting and have diarrhoea. After a few days of illness hemorrhagic manifestations occur. Treatment options for CCHF and Lassa viruses are limited, and there is no vaccine available for use in humans. The purpose of the present study was to produce recombinant nucleocapsid protein of Lassavirus and CCHF virus including an aminoterminal His-tag by a Semliki Forest Virus Replicon (pSFV 4.2). The recombinant proteins are planned to be used in future development of diagnostic methods.</p>

Several plant defense systems consist of enzymes that act on glucosides and produce a toxic compound. In the intact plant tissue the substrate and enzyme are kept apart. The system studied here consists of the substrate 2-O-β-D-glucopyranosyl-4-dihydroxy-1,4-benzoxazin-3-one and the enzyme glucan 1,3-β-glucosidase in rye. The aim was to determine the properties of a cell wall β-glucosidase. Two different systems for expression and purification of β-glucosidase fused to a tag were used: a 6xHistidine tag system and a thioredoxin tag system. The sequence of the β-glucosidase had previously been determined so now the gene was subcloned into E.coli. A direct PCR on colonies, a test expression, a restriction digestion of plasmids and sequencing was made to analyze the transformation, which all turned out successful. Then the β-glucosidase solubility was determined. Finally a purification of the β-glucosidase from E.coli under native conditions and a pNPG assay was carried out. For the (His)6-tagged protein, the recombinant β-glucosidase tended to end up in the insoluble pelleted fraction which indicated formation of inclusion bodies. The cell wall 1,3-β-glucosidase was soluble with the thioredoxin system, but the percentage of soluble protein fraction was around 5% only of the total protein. In eluates from a nickel-nitrilotriacetic acid column the presence of recombinant protein was confirmed with Western blot, but contaminating bands were also present. Purified elauted fractions did not exhibit detectable β-glucosidase activity. It was not possible to purify active enzyme. From a BLAST search it was clear that the most similar enzymes all had putative glycosylation sites and lack of glycosylation could be a reason for the protein not to fold properly.

Abstract Crimean-Congo Hemorrhagic Fever virus (CCHF) and Lassa virus are giving sources illness to humans. In addition to zoonotic transmission, CCHF and Lassa virus can spread from person to person. After a short incubation period, CCHF and Lassa virus infections are characterized by a sudden onset of high fever, chills, headache and cough just like flu. Even some people are vomiting and have diarrhoea. After a few days of illness hemorrhagic manifestations occur. Treatment options for CCHF and Lassa viruses are limited, and there is no vaccine available for use in humans. The purpose of the present study was to produce recombinant nucleocapsid protein of Lassavirus and CCHF virus including an aminoterminal His-tag by a Semliki Forest Virus Replicon (pSFV 4.2). The recombinant proteins are planned to be used in future development of diagnostic methods.

Enquanto as células humanas sintetizam purinas pela via de novo e pela via de recuperação, protozoários parasitas as sintetizam somente pela via de recuperação. Por essa razão, as enzimas que compõem essa via são importantes alvos para o desenvolvimento de novas drogas antiparasitárias. A enzima APRT converte adenina e &#945-D-5-fosforibosil 1-pirofosfato (PRPP) a AMP na via de recuperação de purinas. Nesse trabalho, a APRT e a APRT-His recombinantes foram caracterizadas por métodos bioquímicos e espectroscópicos. As expressões do gene aprt contidos nos vetares pET29+ (Novagen) e pQE30 (Qiagen) renderam 5 e 10 mg.mL-1 de APRT e APRT-His, respectivamente, na forma solúvel. A APRT permaneceu estável e homogênea in vitro em Tris pH 7,5 contendo 5 mM de MgSO4 e 150 mM de KCl mas a APRT-His mostrou-se instável e insolúvel nesse pH e acima de 0,5 mg.mL-1. O estudo de solubilidade revelou que a APRT-His é parcialmente estabilizada em Tris pH 8,5 contendo 150 mM de KCl devendo ser purificada e mantida nesse tampão durante os ensaios espectroscópicos e a adição de 50 mM de histidina mostrou-se eficiente para a concentração da enzima até 8mg.mL-1. A caracterização bioquímica da APRT e da APRT-His revelou que elas são diméricas nos seus tampões e têm PI igual a 6,45 &#177 0,20 e 7,7 &#177 0,16, respectivamente. Os ensaios de atividade enzimática indicaram que a APRT é duas vezes mais ativa do que a APRT-His. Os espectros de CD da APRT-His foram mais intensos do que os espectros da APRT e mostraram perfil de hélice &#945 . Os resultados da desconvolução revelaram que a APRT-His tem cerca de 10% mais hélice-&#945 do que a APRT. O valor de teor de estrutura secundária da APRT equivale aos valores extraídos dos dados cristalográficos da APRT de L donovani e de L tarentolae. Os espectros de emissão de fluorescência mostraram que a APRT-His e a APRT possuem máximos de emissão em 342 e 332 nm, respectivamente. Além disso, eles indicaram que o PRRP e o AMP suprimem a fluorescência do Trp presente na APRT. A supressão foi relacionada à posição dos ligantes localizados no sítio ativo da enzima e a ausência de supressão nas amostras de APRT-His foi relacionada à presença de Mg2+. Os resultados indicam que a presença dos resíduos de histidina na região N-terminal da APRT-His induziu a modificação estrutural da enzima levando a precipitação contínua. Nesse sentido, a ausência dos resíduos de histidina incorporados à enzima favoreceu a estabilidade da proteína in vitro. / Human cells synthesize purine nucleotide by again and salvage pathways, while parasitic protozoa use only salvage pathways. For this reason, the enzymes that compound the salvage pathway are important targets to development of new antiparasitic drugs. The enzyme adenine phosphoribosyltransferase (APRT) converts adenine and &#945-D-5-phosphoribosyll-pyraphosphate (PRPP) to adenosine monophosphate (AMP) at salvage pathway. In this work, the APRT and APRT-His recombinants had been characterized by biochemical and spectroscopic methods. The expression of the aprt genes from L. tarentolae inserted into pET29+ (Novagen) and pQ30 (Qiagen) vectors yielded 5 and 10 mg.mL-1 of the APRT and APRT-His, on soluble form, respectively. The APRT remained stable and homogeneous in vitro at Tris pH 7.5 containing 5 mM MgSO4 and 150 mM KCl, but APRT-His was instable and insoluble above 0.5 mg.mL-1 at the same pH. The solubility study showed that histidine increased the APRT-His solubility and it is partially stabilized at Tris pH 8.5 containing 150 mM KCl. The addition of the histidine 50 mM was efficient for concentrations up to 8 mg.mL-1.Then, the APRT-His was purified and storage in that buffer for spectroscopic assays. The biochemical characterization of the APRT and APRT-His indicated that a both are dimercs in its buffers, and they have isoelectric points at pH 6.45 &#177 0.20 and 7.7 &#177 0.16, respectively. By enzymatic activity assays, the APRT is twice activer than APRT-His. The CD spectra of the APRT-His were more intense than the APRT spectra. and showed helix &#945 profile. The fluorescence spectra marked a maximum emission fluorescence at 342 nm for the APRT-His and 332 um for the APRT. In addition, the spectra revealed that PRPP and AMP quenched the fluorescence of the tryptophan (Trp) into APRT. The quench was related to position of the ligands inside active site of the enzyme and the absent of fluorescence of the Trp, inside APRT-His, was related to absent of the Mg2+. The results has demonstrated that the presence of the histidine residues at N-terminal region of the APRT-His induced to conformational changes of the enzyme following to continuos precipitation. In the same sense, the absent of histidine residues associated to enzyme favored to stability of the protein in vitro.

Recombinant tags are used extensively in protein expression systems to allow purification through IMAC (Immobilized Metal Affinity Chromatography), identification through Western blot, and to facilitate crystal formation for structural analysis. While widely used, their role in enzyme characterization has raised concerns with respect to potential impact on activity. In this study, a flavonol-specific 3-O glucosyltransferase (Cp3GT) from grapefruit (Citrus paradisi) was expressed in Pichia pastoris, and was assayed in its untagged form and with a C-terminal c-myc/6x His tag under various conditions to determine the effect of tags. Prior characterization of pH optima for Cp3GT obtained through expression in Escherichia coli, containing an N-terminal thioredoxin/6x His tag, indicated an optimal pH of 7–7.5, which is indicative of a normal physiological pH and agrees with other glucosyltransferase (GT) pH optima. However, characterization of Cp3GT expressed using P. pastoris with a C-terminal c-myc-6x His tag showed a higher optimal pH of 8.5–9. This suggests a possible tag effect or an effect related to physiological differences between the cell expression systems. Results testing recombinant Cp3GT expressed in Pichia with and without C-terminal tags showed a possible tag effect with regard to substrate preference and interactions with metals, but no apparent effect on enzymatic kinetics or pH optima.

Im Rahmen dieser Arbeit wurden neuartige Modifikationen von Elektrodenoberflächen zur spezifischen und unspezifischen Immobilisierung von Proteinen im Hinblick auf die massenspezifische und voltammetrische Erfassung von Proteinwechselwirkungen untersucht. Im Zusammenhang mit der massenspezifischen Erfassung von Proteinwechselwirkungen wurde eine Kleinst-Volumen-Messzelle (Vi = 80 µl) entwickelt, die, mit einem 5 MHz-Quarz ausgestattet, ein Rauschen von Δf = ± 0.1 Hz und eine Langzeitstabilität in wässrigem Milieu von etwa 1-2 Hz / h aufweist. Die Zelle wurde in einer Weiterentwicklung mit Referenz- und Gegenelektrode ausgestattet, die simultane elektrochemische und mikrogravimetrische Messungen ermöglichte. Es wurde ein vollständiger Messplatz eingerichtet, bestehend aus thermostatisierter Kleinst-Volumen-QCM-Messzelle und digitaler Datenerfassung. Die unspezifische Adsorption von Proteinen auf Goldoberflächen ergab mit der Quarzmikrowaage typischerweise Frequenzabnahmen von 10-80 Hz bei Messzeiten von 10 bis 60 min. Durch Modifikation der Goldoberfläche mit einem in der Literatur beschriebenen Oligoethylenoxid-terminierten Alkylthiol konnte die unspezifische Adsorption von Proteinen auch auf modifizierten Quarzmikrowaagen deutlich herabgesetzt werden. Zur reversiblen, spezifischen Modifikation der QCM-Goldoberfläche wurde eine von Whitesides et al. eingeführte Modifikationsmatrix auf die QCM-Oberfläche übertragen. His-TAG modifizierte EF1-ATPase wurde stabil und reversibel an der modifizierten Oberfläche gebunden, die spezifische Proteinbindung an der Oberfläche konnte chemisch ein- und ausgeschaltet werden. Die Dichte der Proteinbindungsstellen in der Immobilisierungs-Matrix liess sich durch einen molekularen Verdünner kontrollieren. Die prinzipielle Eignung der verwendeten Kombination von Sensortechnik (QCM) und Oberflächenmodifikation für biochemische Affinitätsstudien wurde demonstriert. Im Zusammenhang mit Modifikationen von ITO-Substraten wurde ein neuartiger Redoxindikator eingeführt, der es prinzipiell ermöglicht, die Ni-NTA-modifizierten Oberflächen zu charakterisieren und bezüglich der Dichte spezifischer Protein-Bindungsstellen zu quantifizieren. Die Synthese weiterer Redoxindikatoren mit Thiol-Funktion wird beschrieben. Von besonderer Bedeutung sind elektrochemische Studien an unspezifisch auf Gold adsorbierten Proteinschichten mit hochgeladenen Redoxindikatoren in Lösung. Diese Untersuchungen wurden an 15 verschiedenen Proteinen mit unterschiedlichem isoelektrischen Punkten durchgeführt. Nur wenn Protein und Redoxmarker gegensinnig geladen waren, wurden Redoxströme beobachtet (wie bereits in der Literatur beschrieben). Es konnte nun allerdings erstmals gezeigt werden, dass die geladene Redoxspezies an gegensinnig geladenen Protein-Domänen bindet und dass der Elektronentransfer durch die Proteinschichten in Form einer Elektronentransfer- bzw. Selbstaustausch-Kette zwischen Redoxspezies in Lösung und oberflächenakkumlierter Redoxspezies abläuft. Sogenannte "Analyten", d.h. (Molekül-)Ionen, die mit dem Protein eine elektrostatische Wechselwirkung eingehen, können diese Elektronentransferkette positiv oder negativ beeinflussen. Sie können deshalb an einer Modulation der Stromstärke erkannt werden. Der Elektronentransfer wird durch die beeinflussenden Parameter verstärkt (Induktion) oder vermindert (Suppression). Damit wurde erstmals das in der Literatur beschriebene "Ion-Channel-Sensing" generell mechanistisch aufgeklärt.

京都大学 / 0048 / 新制・課程博士 / 博士(工学) / 甲第18303号 / 工博第3895号 / 新制||工||1598(附属図書館) / 31161 / 京都大学大学院工学研究科合成・生物化学専攻 / (主査)教授 濵地 格, 教授 森 泰生, 教授 跡見 晴幸 / 学位規則第4条第1項該当 / Doctor of Philosophy (Engineering) / Kyoto University / DGAM

The bacterium Chlamydia trachomatis is the leading cause of bacterial sexually transmitted infection worldwide. When left untreated, chlamydial infections can lead to severe complications, such as infertility. Lack in current prevention and management due to its asymptomatic course of infection highlight the need for an effective vaccine against chlamydia. There is no vaccine at present to protect against chlamydia, but research is ongoing. A research group at Örebro University has developed a protein antigen candidate. This project focused on the production of the candidate, here called Protein X, for preclinical trials. This included optimising production in Escherichia coli to maximise formation of soluble protein, optimising purification, buffer exchange and removal of His-tag. It was found that formation of soluble protein was favoured in lower expression temperatures. Furthermore, purification was performed on soluble and insoluble protein fractions using immobilised metal affinity chromatography. However, issues with inefficient binding to the resin and purity could not be solved and further optimisation is needed. Buffers were tested to find a suitable buffer for preclinical experiments, but the protein precipitated in all buffers. It was however found that protein from the insoluble fraction dissolved in pure water. Lastly, removal of the His-tag was performed with a non-enzymatic method that utilises nickel ions instead of expensive proteases. Efficient removal was however not achieved and enzymatic methods may be considered instead. In conclusion, this project highlighted issues in the production of Protein X and may guide the research group towards improving this process for efficient preclinical preparations.

No description available.